Shares of ResMed Inc. which have been pounded in recent weeks by concerns that the obesity-drug craze could hurt demand for the company’s sleep therapy.
By Dominic Chopping Novo Nordisk launched its hugely popular Wegovy injectable weight-loss drug in the U.K. Monday, despite continuing challenges the company.